The effect of N-nitro-L-arginine methyl ester on cocaine-induced hormonal changes in mice

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 4, 1998, Pages 340-345

  Budziszewska, B ^a   Leskiewicz M ^a   Jaworska Feil, L ^a   Lason W ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Cocaine; Corticosterone; L NAME; Mice; Nitric oxide; Testosterone

Indexed keywords

COCAINE; CORTICOSTERONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 0031664296     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211995     Document Type: Article

References (31)

1. Adams ML, Meyer ER, Cicero TJ: Effects of nitric oxide-related agents on opioid regulation of rat testicular steroidogenesis. Biol Reprod 54: 1128-1134, 1996
2. Adams ML, Meyer ER, Sewing BN, Cicero TJ: Effects of nitric oxide-related agents on rat testicular function. J Pharmacol Exp Ther 269: 230-237, 1994
3. G-nitro-L-arginine and comparisons to alkohol. Life Sci 50: PL35-PL40, 1992
4. Budziszewska B, Jaworska-Feil L, Lasoń W: The effect of repeated amphetamine and cocaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. Exp Clin Endocrinol Diabetes 104: 334-338, 1996
5. Canteros G, Rettori V, Franchi A, Genaro A, Cebral E, Faletti A, Gimeno M, McCann SM: Ethanol inhibits luteinizing hormone-releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide. Proc Natl Acad Sci USA 92: 3416-3420, 1995
6. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T: Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90: 11292-11296, 1993
7. Cole BJ, Cador M, Stinus L, Rivier C, Rivier J, Vale W, Le Moal M, Koob G.F: Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci 47: 1715-1720, 1990
8. Del Punta K, Charreau EH, Pignataro OP: Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 137: 5337-5343, 1996
9. Dluzen DE., Green MA., Ramirez VD: The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat. Horm Behav 20: 1-6, 1986
10. Fuller RW, Snoddy HD: Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology 109: 1026-1032, 1981
11. Giordano M, Vermulen M, Trevani AS, Dran G, Andonegui G, Geffner JR: Nitric oxide synthase inhibitors enhance plasma level of corticosterone and ACTH. Acta Physiol Scand 157: 259-264, 1996
12. Hernandez L, Gonzalez L, Murzi E, Paez X, Gottberg E, Baptista T: Testosterone modulates mesolimbic dopaminergic activity in male rats. Neurosci Lett 171: 172-174, 1994
13. Holman BB: Biological effects of central nervous system stimulants. Addiction 89: 1435-1441, 1994
14. Karanth S, Lyson K, McCann SM: Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90: 3383-3387, 1993
15. G-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221: 399-400, 1992
16. Majeed NH, Przewłocka B, Machelska H, Przewlocki R: Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33: 189-192, 1994
17. McEwen B: Endocrine effects on the brain and their relationship to behavior. In: Siegel GJ (ed.). Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, pp. 893-913, Raven Press, Ltd, New York, 1989
18. McEwen B: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12: 141-146, 1991
19. Naik SR, Kelkar MR, Sheth UK: Attenuation of stereotyped behaviour by sex steroids. Psychopharmacology Berl 57: 211-214, 1978
20. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rouge-Pont F, Maccari S, Le-Moal M, Simon H: Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658: 259-264, 1994
21. Przegaliński E, Budziszewska B, Błaszczyńska E: Repeated treatment with antidepressant drugs and/or electroconvulsive shock does not affect the quinpirole-induced elevation of the serum corticosterone concentration in rats. J Psychopharmacol 4: 198-203, 1990
22. Przegaliński E, Budziszewska B, Grochmal A: Effect of adenosine analogues on plasma corticosterone concentration in rats. Acta Endocrinol 127: 471-475, 1992
23. Przewłocka B, Turchan J, Machelska H, Labuz D, Lasoń W: Nitric oxide synthase inhibitor L-NAME prevents amphetamine-induced prodynorphin gene expression in the rat. Prog Neuro-Psychopharmacol Biol Psychiat 20, 1229-1237, 19
24. Raber J, Koob GF, Bloom FE: Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272: 815-824, 1995
25. Sandi C, Venero C, Guaza C: Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats. Neuroendocrinology 63: 446-453, 1996
26. Saphier D, Welch JE, Farrar GE, Goeders NE: Effects of intracerebroventricular and intrahypothalamic cocaine administration on adrenocortical secretion. Neuroendocrinology 57: 54-62, 1993
27. Sarnyai Z, Biro E, Telegdy G: Cocaine-induced elevation of plasma corticosterone is mediated by different neurotransmitter systems in rats. Pharmacol Biochem Behav 45: 209-214, 1993
28. Sarnyai Z, Biro E, Penke B, Telegdy G: The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res 589: 154-156, 1992
29. Snyder GD, Holmes RW, Bates JN, Van Voorhis BJ: Nitric oxide inhibits aromatase activity: mechanisms of action. J Steroid Biochem Molec Biol 58: 63-69, 1996
30. Welch C, Watson ME, Poth M, Hong T, Francis GL: Evidence to suggest nitric oxide is an interstitial regulator of Leydig cell steroidogenesis. Metabolism 44: 234-238, 1995
31. Zhu XZ, Luo LG: Effect of nitroprusside (nitric oxide) on endogenous dopamine release from striatal slices. J Neurochem 59: 932-935, 1992